CaPre

DRUG2 trials

Sponsors

Grace Therapeutics Inc.

Conditions

Hypertriglyceridemia

Phase 3

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

CompletedNCT03361501

Grace Therapeutics Inc.Hypertriglyceridemia

Start: 2018-02-01End: 2020-01-09Updated: 2020-08-12

A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)

CompletedNCT03398005

Grace Therapeutics Inc.Hypertriglyceridemia

Start: 2018-01-23End: 2019-11-20Updated: 2020-01-18

Related Papers

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia

JAMA Network Open2022-01-0622 citations